EQ
Equillium Inc
NASDAQ: EQ · HEALTHCARE · BIOTECHNOLOGY
$2.08
+1.46% today
Updated 2026-04-29
Market cap
$136.57M
P/E ratio
—
P/S ratio
20.22x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$0 – $3
Volume
0.5M
Equillium Inc (EQ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-94.00%
ROA
-51.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-2.26M | — | — | — |
| 2018 | $0.00 | $-13.25M | — | — | — |
| 2019 | $0.00 | $-25.58M | — | — | — |
| 2020 | $0.00 | $-29.77M | — | — | — |
| 2021 | $0.00 | $-38.98M | — | — | — |
| 2022 | $15.76M | $-62.43M | 100.00% | -393.91% | -396.14% |
| 2023 | $36.08M | $-13.34M | 100.00% | -40.24% | -36.96% |
| 2024 | $41.09M | $-8.07M | 100.00% | -20.12% | -19.63% |
| 2025 | $130000.00 | $-22.40M | 50.00% | -18,180.00% | -17,229.23% |